Mikkel has an MSc in Economics from Copenhagen University. He has over 20 years of extensive experience in corporate finance, strategy, and business development from positions at IO Biotech, H. Lundbeck, and Genmab. He participated in several large licensing deals and funding rounds. He participated in the IPO of IO Biotech at Nasdaq Global Markets in November 2021. E-mail: md@hobatherapeutics.com